Julia Kirshner

Julia Kirshner

Company: zPREDICTA

Job title: Founder & CEO


Julia has over 20 years of experience in oncology R&D spanning multiple areas of cancer biology, including: the development of organotypic preclinical models, molecular target and biomarker discovery, evaluation of drug-resistance, tumor microenvironment, cancer stem cells, and tumor immunology. Prior to founding zPREDICTA, Julia held a faculty appointment at the Department of Biological Sciences at Purdue University working on the mechanisms of cancer development and spread and the effects of tissue microenvironment on drug response. Subsequently, Julia founded zPREDICTA with a goal to develop tumor-specific 3D culture models reconstructing the native microenvironment of human tissues to mimic the drug behavior as seen in patients. From target discovery and lead optimization to preclinical evaluation of efficacy and toxicity, zPREDICTA’s goal is to develop the tools necessary to accurately identify compounds that will have the highest probability of improving human health.

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.